Females with Schizophrenia for Clinical Trials

​Update on COVID-19

To: Our Sponsors, CROs, Patients, and Employees

At CenExel Clinical Research, our top priorities are the safety and health of our patients and employees. For our Centers of Excellence to provide the highest quality of clinical research, we established and maintain a COVID-19 Task Force with representatives from every Center. The Task Force is charged with continuous monitoring of the pandemic and providing guidance and communication.

Our clinical operations continue, and we have implemented the following additional safety measures:

• Enhanced screening of everyone entering any of our facilities before they are admitted into our offices or clinical areas
• Reinforced internal communication regarding the COVID-19 situation, CDC and SHRM recommendations, digital team meetings, and the importance of using sick leave for anyone who has signs, symptoms, or recent exposure to someone with suspected or diagnosed COVID-19
• Additional cleaning and disinfecting materials provided through our clinic and office areas
• Cross-training and preparations for contingency plans if key staff need to stay home

We will continue to monitor the current situation, coordinate with the proper authorities, and update our policies and procedures as needed to ensure the safety of our patients and employees.

*If you submit a testimonial to us through our website or any of our social media channels, you agree that we may publish your testimonial, in whole or in part. Although we reserve the right to edit your testimonial, we will never do so in such a way as to create a misleading impression of your views. You also agree that your testimonial may be published together with your name on any CenExel website, marketing material, digital medium, or any other channel at our discretion. You may terminate this license of use of your testimonial and/or your name with a written notice of termination and allowing up to 30 days for us to comply.